Clinical decision support tool. Does not replace professional veterinary judgment. Always verify recommendations with current references.

Vizsla Dog — Clinical Risk Profile | VetTools | VetTools Clinical Intelligence

Vizsla

DOG· MEDIUM· Lifespan: 12-14 years

Thinking about this breed for your home? Read the owner suitability guide

📋 Breed Predispositions

Condition	Prevalence	Onset	Severity	Screening
Lymphoma and Mast Cell Tumour	Over-represented	5-10 years	LIFE THREATENING	Aspirate every new skin mass rather than monitoring it, and palpate all peripheral lymph nodes at every visit.
Idiopathic Epilepsy	Over-represented	1-5 years	SEVERE	Minimum database plus bile acids to exclude metabolic causes; owner seizure diary.
Inflammatory Polymyopathy (Vizsla Myositis)	Breed-specific	1-5 years	SEVERE	Masticatory muscle atrophy, difficulty opening the jaw, drooling or dysphagia. 2M antibody titre and muscle biopsy; megaesophagus is a common and dangerous companion finding.
Sebaceous Adenitis	Breed-associated	1-5 years	MODERATE RISK	Punch biopsy for nodular or diffuse alopecia with scaling — the Vizsla form often presents as discrete nodules rather than the Poodle pattern.
Hip Dysplasia	Lower than most sporting breeds but present	1-2 years	MODERATE RISK	OFA or PennHIP evaluation by age 2.
Hypothyroidism	Elevated	4-8 years	MILD	Total T4 with TSH annually after age 4.